#DayTrading #Trading #Investing #Trader #StockMarket #DayTrader #Finance
The #Stocks I traded today are $GILD $JPM… https://t.co/FO9m9fYEoA
RT @DZalkowitz: $GILD - needs another M&A deal BADLY after $JNJ HIV two-drug regimen data; $GILD getting hurt in HIV by $GSK, $JNJ, $MRK a…
RT @ShockExchange: Endo: Women Discuss Commercial Appeal For Xiaflex To Treat Cellulite https://t.co/yXMHC3FEW2 … $ENDP $AGN $BHC $GILD $HO…
Endo: Women Discuss Commercial Appeal For Xiaflex To Treat Cellulite https://t.co/yXMHC3FEW2 … $ENDP $AGN $BHC… https://t.co/kMEIlDEUJG
RT @AndyBiotech: The tide is turning and the rebate bubble is finally bursting!
Insulin: $LLY to launch authorized generic Humalog at 50%…
$GILD:
Gilead Announces Data From Two Studies Supporting Further …:
https://t.co/xGZYvd6E6B
$GILD Gilead Announces Data From Two Studies Supporting Further Development of GS-6207, a Novel, Investigatio
From our Stock News Alerts App
$GILD Data From Two Studies Supporting Further Development of GS-6207, a Novel, Investigational HIV-1 Capsid Inhibi… https://t.co/MTwIkaAGU4
$FB $BABA $AAPL $FCX $FFIV $FIT $GE $CVS $GILD $GM $GE $CELG $CGC $GS $HAL $HD $HDS $HON $HPQ $IBM $CTRP $CTSH… https://t.co/z2mn3wSbTf
$DE $DIS $MCD $NICE $AAPL $CHK $SWKS $SWN $HON $NFLX $GILD $IWM $QQQ $CRON $BABA $WATT $CRON $ROKU $BMY $ABBV $ADBE… https://t.co/kIoabsE87D
$SQ $JD $BOX $CELG $BKNG $BILI $SQ $GILD $QCOM $TSLA $WTW $AMRN $FIT $JD $IMGN $CVS $OSTK $PANW $BBY $FIT $LOW $WTW… https://t.co/iyUOKuixVs
$SPY $QQQ $IWM $LEN $SWKS $GMED $DVN $X $KNDI $CGC $INTC $SGH $TRX.X $BBBY $NIO $CVS $UCO $USO $WYNN $BIDU $GILD… https://t.co/UPh8PmPTJf
$WMT $TEVA $NWL $SPY $BAC $AMBA $GILD $CELG $ROKU $CPRI $FB $AAPL $BMY $LVS $M $SPY $QQQ $IWM $TGT $ROST $CGC $STZ… https://t.co/YyjzuyI8jQ
RT @Briefingcom: $GILD: Gilead Sciences reports data from two studies supporting further development of GS-6207 -- an HIV-1 capsid... https…
RT @Briefingcom: $GILD: Gilead Sciences reports data from two studies supporting further development of GS-6207 -- an HIV-1 capsid... https…
$GILD: Gilead Sciences reports data from two studies supporting further development of GS-6207 -- an HIV-1 capsid... https://t.co/zJz6GqCTMS
Gilead Sciences $GILD: Piper Jaffray Reaffirms "Hold" Rating Today, Has a Target of $75/Share https://t.co/I5CP39Li7O
19.94 % to Target, Piper Jaffray Reaffirms ‘Hold’ Rating on Gilead Sciences $GILD Shares Today https://t.co/07aXN1VqDI
Gilead Sciences, Inc. $GILD Receives Average Recommendation of “Hold” from Brokerages https://t.co/0bdfJ1oF9W
Analysts Set Gilead Sciences, Inc. $GILD PT at $82.33 https://t.co/ltpRUJpI1K
Gilead Sciences $GILD Announces Data From Two Studies Supporting Further Development of GS-6207
https://t.co/iCA8ySbVi7
Don't miss our next FREE OPTION TRADE. Sign up for our Daily Free Trades at https://t.co/LxYIZDgKcj $NVDA $TSLA $GS $GILD $F $GOOGL $FB
07 MAR 2019 - Evening Update | LargeCap Stocks
$GILD @ $62.53
Combined Score: +33.0
Sentiment: BULLISH
Confidence:… https://t.co/ASVW6m3nVJ
$GILD:
Gilead’s GS-6207 shows encouraging action in early-stage studies:
https://t.co/ekrigBeICU
$GILD - Gilead's GS-6207 shows encouraging action in early-stage studies https://t.co/YW4VvktWqu
I think this will pop! tomorrow premarket (dont trade the news)
$GILD - Gilead's GS-6207 shows encouraging action… https://t.co/kJkMTWeSOF
GOT #PENNYSTOCKS??
ON MARCH 12TH , EXPECT THE Mega GODZILLA ALERT TO BE THE BIGGEST RUNNER IN #PENNYSTOCKS HISTOR… https://t.co/kbGHaeDxuW
FEATURED: $QBIO Growth Potential Written All Over Q BioMed (OTCQB:QBIO)’s Pipeline https://t.co/0YQTUCuplE $IBB… https://t.co/JcgZE8nxzu
Investor Outlook: Gilead Sciences $GILD "Buy" Rating Reiterated at J.P. Morgan Today https://t.co/OqVRjmPrJ9
Analyst at J.P. Morgan Reaffirmed The Gilead Sciences $GILD Buy Rating They’ve Had https://t.co/pbhD9N7Ryd
Investor Outlook: Gilead Sciences $GILD "Buy" Rating Reiterated by Analysts at J.P. Morgan Today https://t.co/BdBQvuTPdl
$QBIO $RHHBY Autism Spectrum Disorder: 2 Biotech Stocks to Watch in 2019 https://t.co/ROpA6RFWBJ $IBB $GILD $NVS… https://t.co/PUtWMqJLfr
RT @OTC_insider: FEATURED: $QBIO Growth Potential Written All Over Q BioMed (OTCQB:QBIO)’s Pipeline https://t.co/0YQTUCuplE $IBB $GILD $NVS…
RT @daily_otc: $QBIO $RHHBY Autism Spectrum Disorder: 2 Biotech Stocks to Watch in 2019 https://t.co/ROpA6RFWBJ $IBB $GILD $NVS $MRK $BMY $…
RT @OTC_insider: FEATURED: $QBIO Growth Potential Written All Over Q BioMed (OTCQB:QBIO)’s Pipeline https://t.co/0YQTUCuplE $IBB $GILD $NVS…
RT @daily_otc: $QBIO $RHHBY Autism Spectrum Disorder: 2 Biotech Stocks to Watch in 2019 https://t.co/ROpA6RFWBJ $IBB $GILD $NVS $MRK $BMY $…
RT @OTC_insider: FEATURED: $QBIO Growth Potential Written All Over Q BioMed (OTCQB:QBIO)’s Pipeline https://t.co/0YQTUCuplE $IBB $GILD $NVS…
RT @daily_otc: $QBIO $RHHBY Autism Spectrum Disorder: 2 Biotech Stocks to Watch in 2019 https://t.co/ROpA6RFWBJ $IBB $GILD $NVS $MRK $BMY $…
RT @OTC_insider: FEATURED: $QBIO Growth Potential Written All Over Q BioMed (OTCQB:QBIO)’s Pipeline https://t.co/0YQTUCuplE $IBB $GILD $NVS…
RT @daily_otc: $QBIO $RHHBY Autism Spectrum Disorder: 2 Biotech Stocks to Watch in 2019 https://t.co/ROpA6RFWBJ $IBB $GILD $NVS $MRK $BMY $…
RT @OTC_insider: FEATURED: $QBIO Growth Potential Written All Over Q BioMed (OTCQB:QBIO)’s Pipeline https://t.co/0YQTUCuplE $IBB $GILD $NVS…
RT @daily_otc: $QBIO $RHHBY Autism Spectrum Disorder: 2 Biotech Stocks to Watch in 2019 https://t.co/ROpA6RFWBJ $IBB $GILD $NVS $MRK $BMY $…
HUGE RULING HANDED DOWN $MTG $XLV $CELG $ENDP $GILD $CZR $NGD $LUV $HAL $GERN $GLD $AIG $WMT $LC $JCI $GLW $AKER… https://t.co/O5zgKzwqPi
HUGE RULING HANDED DOWN $GNPX $CYAD $KN $BOOM $SIVB $ENVA $DNJR $EXAS $EHTH $CHKE $FLEX $CHTR $LBRDK $TNDM $FII… https://t.co/wmlEt7gpi7
RT @SmallCapTipsSs: $QBIO $SRPT $VRTX Top 3 Biotech Stocks To Watch in 2019: Q BioMed Inc., (OTCQB: QBIO), Sarepta Therapeutics (NASDAQ:SRP…
RT @SmallCapTipsSs: $QBIO $SRPT $VRTX Top 3 Biotech Stocks To Watch in 2019: Q BioMed Inc., (OTCQB: QBIO), Sarepta Therapeutics (NASDAQ:SRP…
RT @SmallCapTipsSs: $QBIO $SRPT $VRTX Top 3 Biotech Stocks To Watch in 2019: Q BioMed Inc., (OTCQB: QBIO), Sarepta Therapeutics (NASDAQ:SRP…
$GSK $NVS $GILD $AGEN:
Gilead Reports Positive Data on HIV Drugs Biktarvy & Descovy:
https://t.co/8zzLkjifuI
RT @SmallCapTipsSs: $QBIO $SRPT $VRTX Top 3 Biotech Stocks To Watch in 2019: Q BioMed Inc., (OTCQB: QBIO), Sarepta Therapeutics (NASDAQ:SRP…
RT @SmallCapTipsSs: $QBIO $SRPT $VRTX Top 3 Biotech Stocks To Watch in 2019: Q BioMed Inc., (OTCQB: QBIO), Sarepta Therapeutics (NASDAQ:SRP…
price x volume leaders - $AMZN $NFLX $AAPL $EA $MSFT $FB $NVDA $TSLA $GOOG $MU $AMD $GOOGL $BABA $BAC $BA $ELLI… https://t.co/1rObCIEfDi
$QBIO $SRPT $VRTX Top 3 Biotech Stocks To Watch in 2019: Q BioMed Inc., (OTCQB: QBIO), Sarepta Therapeutics (NASDAQ… https://t.co/iswuFwOBEd
Zacks: Brokerages Anticipate Gilead Sciences, Inc. $GILD Will Announce Quarterly Sales of $5.33 Billion https://t.co/NVrjbMRNIB
Zacks: Brokerages Anticipate Gilead Sciences, Inc. $GILD Will Announce Quarterly Sales of $5.33 Billion https://t.co/jf8eykdcxJ #stocks
Gilead Sciences, Inc. $GILD Expected to Post Quarterly Sales of $5.33 Billion https://t.co/kg6ZHreIUu
Which stocks are you excited about $BABA $APPL $NFLX $ABBV $DPW $BPTH $WTW $SPOT $SPY $DJIA $GILD $XOM $TVIX
Gilead Sciences $GILD PT Set at $75.00 by Piper Jaffray Companies https://t.co/oDTaePFcJ4
Gilead Sciences $GILD PT Set at $75.00 by Piper Jaffray Companies https://t.co/soKKUHqFUd
$SGMO $CLLS $CRSP $EDIT $NTLA $ALCLS $PFE $GILD $CELG $BMY https://t.co/hfE1EegROa
$QBIO Growth Potential Written All Over Q BioMed (OTCQB:QBIO)’s Pipeline https://t.co/nsr9q0jhU7 $IBB $GILD $NVS… https://t.co/rfKJsj9i9V
$QBIO Q BioMed Announces Strategic Partnership With SRI International for Formulation and Preclinical Development o… https://t.co/C86JdgURe9
$QBIO Q BioMed's Autism Spectrum Disorder Drug Development Program Featured in February Issue of Leading Pharma/Bio… https://t.co/48kfLcauRc
$QBIO $VRTX $SRPT Top 3 Biotech Stocks To Watch in 2019: Q BioMed Inc., (OTCQB: QBIO), Sarepta Therapeutics (NASDAQ… https://t.co/XwCwFIwBE9
$GILD $AZO $YUM options have the largest change in open interest. Free options screener. https://t.co/PxpfBF7b5M
RT @MomentumBeats: $QBIO Growth Potential Written All Over Q BioMed (OTCQB:QBIO)’s Pipeline https://t.co/nsr9q0jhU7 $IBB $GILD $NVS $PFE $A…
RT @247BiotechNews: RE: $QBIO Growth Potential Written All Over Q BioMed (OTCQB:QBIO)’s Pipeline https://t.co/NhV6Taz47v $IBB $GILD $NVS $P…
RE: $QBIO Growth Potential Written All Over Q BioMed (OTCQB:QBIO)’s Pipeline https://t.co/NhV6Taz47v $IBB $GILD… https://t.co/I9lpmvqxkH
RT @247BiotechNews: RE: $QBIO $RHHBY Autism Spectrum Disorder: 2 Biotech Stocks to Watch in 2019 https://t.co/sQg8G8L3S0 $IBB $GILD $NVS $M…
RE: $QBIO $RHHBY Autism Spectrum Disorder: 2 Biotech Stocks to Watch in 2019 https://t.co/sQg8G8L3S0 $IBB $GILD… https://t.co/EWn8Rm2Zky
ACTIVE TRADERS Try one of these FREE trading guides:
https://t.co/3xkJKvn4Ym
$NFLX $TSLA $AAPL $GILD $GS $FB $AMZN $GOOGL $NVDA
It's Motivating Seeing The Continuous Lies About #allergan!
$aapl $amzn $agn $brk $bhc $crm $cmg $tsla $esrx $f… https://t.co/NRhfHebII5
Aratana Therapeutics $PETX Holder Dimensional Fund Advisors LP Has Upped Its Holding by $686,298 as Valuation Decli… https://t.co/WR9LWOnsaX
Gilead Sciences $GILD Given a $75.00 Price Target at Piper Jaffray Companies https://t.co/bBLebSShpm #stocks
RT @MomentumBeats: $QBIO $VRTX $SRPT Top 3 Biotech Stocks To Watch in 2019: Q BioMed Inc., (OTCQB: QBIO), Sarepta Therapeutics (NASDAQ:SRPT…
RT @MomentumBeats: $QBIO Q BioMed's Autism Spectrum Disorder Drug Development Program Featured in February Issue of Leading Pharma/Biotech…
RT @MomentumBeats: $QBIO Q BioMed Announces Strategic Partnership With SRI International for Formulation and Preclinical Development of QBM…
RT @MomentumBeats: $GLPG $QBIO $AXSM The clock's ticking for Axsome Therapeutics (NASDAQ:AXSM), Galapagos (NASDAQ:GLPG) and their experimen…
RT @MomentumBeats: $GILD $QBIO $GLPG Galapagos and its collaboration partner, Gilead , are supposed to release results from two pivotal tr…
RT @247BiotechNews: RE: $GILD $QBIO $GLPG Galapagos and its collaboration partner, Gilead , are supposed to release results from two pivot…
RT @247BiotechNews: RE: $GLPG $QBIO $AXSM The clock's ticking for Axsome Therapeutics (NASDAQ:AXSM), Galapagos (NASDAQ:GLPG) and their expe…
RT @247BiotechNews: $QBIO Q BioMed Announces Strategic Partnership With SRI International for Formulation and Preclinical Development of QB…
RT @247BiotechNews: RE: $QBIO Q BioMed's Autism Spectrum Disorder Drug Development Program Featured in February Issue of Leading Pharma/Bio…
RT @247BiotechNews: RE: $QBIO $SRPT $VRTX Top 3 Biotech Stocks To Watch in 2019: Q BioMed Inc., (OTCQB: QBIO), Sarepta Therapeutics (NASDAQ…
#stockmarket $QBIO $VRTX $SRPT Top 3 Biotech Stocks To Watch in 2019: Q BioMed Inc., (OTCQB: QBIO), Sarepta Therape… https://t.co/498oQp1e8b
#stockmarket $QBIO Q BioMed's Autism Spectrum Disorder Drug Development Program Featured in February Issue of Leadi… https://t.co/ozFJspArYs
#RE $GILD $QBIO $GLPG Galapagos and its collaboration partner, Gilead , are supposed to release results from two p… https://t.co/H8Fj0BMoeS
#stockmarket $GLPG $QBIO $AXSM The clock's ticking for Axsome Therapeutics (NASDAQ:AXSM), Galapagos (NASDAQ:GLPG) a… https://t.co/wRjouPfBct
#stockmarket $QBIO Q BioMed's Autism Spectrum Disorder Drug Development Program Featured in February Issue of Leadi… https://t.co/fueGFaIVwZ
#stockmarket $QBIO Growth Potential Written All Over Q BioMed (OTCQB:QBIO)’s Pipeline https://t.co/gq7gNroGZe …… https://t.co/Vvo9dZGnTw
#stockmarket $QBIO $RHHBY Autism Spectrum Disorder: 2 Biotech Stocks to Watch in 2019 https://t.co/3vVyMu9ySH …… https://t.co/yFu9tcBqZ7
#stockmarket RE: $QBIO $SRPT $VRTX Top 3 Biotech Stocks To Watch in 2019: Q BioMed Inc., (OTCQB: QBIO), Sarepta The… https://t.co/w454DfkOwg
RE: $QBIO $SRPT $VRTX Top 3 Biotech Stocks To Watch in 2019: Q BioMed Inc., (OTCQB: QBIO), Sarepta Therapeutics (NA… https://t.co/I3gODjHjEe
RE: $QBIO Q BioMed's Autism Spectrum Disorder Drug Development Program Featured in February Issue of Leading Pharma… https://t.co/1OFUfArscV
$QBIO Q BioMed Announces Strategic Partnership With SRI International for Formulation and Preclinical Development o… https://t.co/zIz1isMPu1
RE: $GLPG $QBIO $AXSM The clock's ticking for Axsome Therapeutics (NASDAQ:AXSM), Galapagos (NASDAQ:GLPG) and their… https://t.co/Dwh65OICyC
RE: $GILD $QBIO $GLPG Galapagos and its collaboration partner, Gilead , are supposed to release results from two p… https://t.co/kOgp8EgIw3
$GILD $QBIO $GLPG Galapagos and its collaboration partner, Gilead , are supposed to release results from two pivot… https://t.co/aKOLu4pijI
$GLPG $QBIO $AXSM The clock's ticking for Axsome Therapeutics (NASDAQ:AXSM), Galapagos (NASDAQ:GLPG) and their expe… https://t.co/TnjiwVInT7
$AMGN scripts down 3% Q/Q,
$GILD HCV down 19%, HIV down 5%, Dupi up 7% W/W
$BIIB BIIB US MS product total scripts are down 3%
Hartline Investment Increased Visa Class A $V Holding by $969,400 as Share Price Rose; Shareholder Aimz Investment… https://t.co/TWBKcq7GLn
Was #allergan Excluding Rapastinel on 1/29 a Signal of Failure? $aapl $amzn $agn $brk $bhc $crm $cmg $tsla $esrx $f… https://t.co/ZilEGjOOvL